HAP Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,175
Closed -$31K 1219
2022
Q4
$31K Buy
3,175
+1,945
+158% +$274K ﹤0.01% 850
2022
Q3
$26K Buy
1,230
+495
+67% +$56K ﹤0.01% 1130
2022
Q2
$5K Buy
+735
New +$57K ﹤0.01% 1612
2022
Q1
Sell
-655
Closed -$12K 2234
2021
Q4
$12K Sell
655
-271
-29% -$64K ﹤0.01% 1986
2021
Q3
$16K Sell
926
-240
-21% -$68.6K ﹤0.01% 1862
2021
Q2
$32K Sell
1,166
-393
-25% -$156K ﹤0.01% 1648
2021
Q1
$42K Buy
1,559
+339
+28% +$167K ﹤0.01% 1214
2020
Q4
$27K Buy
+1,220
New +$773K ﹤0.01% 1610
2020
Q2
Sell
-2,393
Closed -$26K 1696
2020
Q1
$26K Buy
2,393
+1,366
+133% +$1.33M ﹤0.01% 890
2019
Q4
$102K Buy
1,027
+209
+26% +$227K 0.01% 549
2019
Q3
$19K Sell
818
-54
-6% -$82.5K ﹤0.01% 938
2019
Q2
$60K Sell
872
-116
-12% -$201K ﹤0.01% 703
2019
Q1
$114K Buy
+988
New +$1.74M 0.01% 525
2018
Q3
Sell
-973
Closed -$11K 1001
2018
Q2
$11K Buy
+973
New +$2.22M ﹤0.01% 863
2018
Q1
Sell
-1,822
Closed -$832K 946
2017
Q4
$832K Buy
1,822
+896
+97% +$1.82M 0.03% 305
2017
Q3
$315K Sell
926
-3,135
-77% -$4.38M 0.01% 433
2017
Q2
$170K Buy
+4,061
New +$4.9M 0.01% 533
2015
Q3
Sell
-965
Closed -$50K 1044
2015
Q2
$50K Buy
+965
New +$1.97M ﹤0.01% 659

Other funds holding BLUE

HAP Trading's BLUE Position: Q4 2021 in Review

HAP Trading sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,542 shares — an estimated $600K sold.

HAP Trading first reported a position in BLUE in Q4 2019 and held it in 6 quarters. The position peaked at $1.65M in Q4 2019. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • HAP Trading reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 2,542 bluebird bio shares in Q4 2021, an estimated $600K.
  • HAP Trading first reported a position in bluebird bio in Q4 2019 and held it in 6 quarters.
  • HAP Trading's bluebird bio position peaked at $1.65M in Q4 2019.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.